OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Improved Immune Response to the Third COVID-19 mRNA Vaccine Dose in Hemodialysis Patients
Daisuke Kanai, Hiromichi Wakui, Tatsuya Haze, et al.
Kidney International Reports (2022) Vol. 7, Iss. 12, pp. 2718-2721
Open Access | Times Cited: 12
Daisuke Kanai, Hiromichi Wakui, Tatsuya Haze, et al.
Kidney International Reports (2022) Vol. 7, Iss. 12, pp. 2718-2721
Open Access | Times Cited: 12
Showing 12 citing articles:
Effects of SARS-CoV-2 vaccination on the severity of COVID-19 infection in patients on chronic dialysis
Jing Miao, Elsa Olson, Sally Houlihan, et al.
Journal of Nephrology (2023) Vol. 36, Iss. 5, pp. 1321-1328
Open Access | Times Cited: 9
Jing Miao, Elsa Olson, Sally Houlihan, et al.
Journal of Nephrology (2023) Vol. 36, Iss. 5, pp. 1321-1328
Open Access | Times Cited: 9
Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis
Daisuke Kanai, Hiromichi Wakui, Masaaki Hanaoka, et al.
Clinical and Experimental Nephrology (2023) Vol. 27, Iss. 7, pp. 639-647
Open Access | Times Cited: 6
Daisuke Kanai, Hiromichi Wakui, Masaaki Hanaoka, et al.
Clinical and Experimental Nephrology (2023) Vol. 27, Iss. 7, pp. 639-647
Open Access | Times Cited: 6
Anti-SARS-CoV-2 spike antibody response to the third dose of BNT162b2 mRNA COVID-19 vaccine and associated factors in Japanese hemodialysis patients
Keiji Hirai, Masako Shimotashiro, Toshiaki Okumura, et al.
Kidney Research and Clinical Practice (2024) Vol. 43, Iss. 3, pp. 326-336
Open Access | Times Cited: 1
Keiji Hirai, Masako Shimotashiro, Toshiaki Okumura, et al.
Kidney Research and Clinical Practice (2024) Vol. 43, Iss. 3, pp. 326-336
Open Access | Times Cited: 1
Clinical Course and Factors Correlated with Severe Morbidity and Mortality in Patients with Coronavirus Disease 2019 Undergoing Maintenance Dialysis in Kanagawa, Japan
Kohei Ishiga, Hiromichi Wakui, Kengo Azushima, et al.
Internal Medicine (2024)
Open Access | Times Cited: 1
Kohei Ishiga, Hiromichi Wakui, Kengo Azushima, et al.
Internal Medicine (2024)
Open Access | Times Cited: 1
Dyslipidemia and SARS‐CoV‐2 spike antibody titres after the second and third doses of the BNT162b2 vaccine among healthcare workers in Japan
Zobida Islam, Shohei Yamamoto, Tetsuya Mizoue, et al.
Diabetes/Metabolism Research and Reviews (2022) Vol. 39, Iss. 3
Open Access | Times Cited: 5
Zobida Islam, Shohei Yamamoto, Tetsuya Mizoue, et al.
Diabetes/Metabolism Research and Reviews (2022) Vol. 39, Iss. 3
Open Access | Times Cited: 5
Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis Patients
Takahiro Takazono, Mya Myat Ngwe Tun, Satoshi Funakoshi, et al.
Kidney International Reports (2023) Vol. 8, Iss. 9, pp. 1883-1886
Open Access | Times Cited: 2
Takahiro Takazono, Mya Myat Ngwe Tun, Satoshi Funakoshi, et al.
Kidney International Reports (2023) Vol. 8, Iss. 9, pp. 1883-1886
Open Access | Times Cited: 2
Durable Anti-SARS-CoV-2 Antibody Response after mRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave
Georg F. Beilhack, Rossella Monteforte, Florian Frommlet, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1121-1121
Open Access | Times Cited: 2
Georg F. Beilhack, Rossella Monteforte, Florian Frommlet, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1121-1121
Open Access | Times Cited: 2
Evaluation of commercial assays for the assessment of SARS-CoV-2 antibody response in hemodialysis patients
Ashley Di Meo, Liyan Ma, Kevin Yau, et al.
Clinical Biochemistry (2023) Vol. 121-122, pp. 110681-110681
Closed Access | Times Cited: 2
Ashley Di Meo, Liyan Ma, Kevin Yau, et al.
Clinical Biochemistry (2023) Vol. 121-122, pp. 110681-110681
Closed Access | Times Cited: 2
Effect of Homologous and Heterologous Booster in COVID-19 Vaccination
Marija Vukčević, Mateja Despot, Aleksandra Nikolić‐Kokić, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1734-1734
Open Access
Marija Vukčević, Mateja Despot, Aleksandra Nikolić‐Kokić, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1734-1734
Open Access
Robust antibody response after the third mRNA coronavirus vaccination in Japanese hemodialysis patients
Ryoichi Miyazaki, Kyoko Miyagi, Misaki Yoshida, et al.
Renal Replacement Therapy (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Ryoichi Miyazaki, Kyoko Miyagi, Misaki Yoshida, et al.
Renal Replacement Therapy (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Monitoring strategy of COVID‐19 vaccination in dialysis patients based on a multiplex immunodot method: The CovidDial study
Frederic Debellé, Vo Thanh Phuong Nguyen, Laurence P Boitquin, et al.
Seminars in Dialysis (2023) Vol. 37, Iss. 2, pp. 145-152
Open Access | Times Cited: 1
Frederic Debellé, Vo Thanh Phuong Nguyen, Laurence P Boitquin, et al.
Seminars in Dialysis (2023) Vol. 37, Iss. 2, pp. 145-152
Open Access | Times Cited: 1
血液透析患者におけるモデルナ社製COVID-19ワクチン3回目異種ブースター接種前後のSARS-CoV-2 S1-RBD IgG抗体価の検討
Okuda Kosuke, Azusa Takahashi, Yoichi Furusawa, et al.
Nihon Toseki Igakkai Zasshi (2023) Vol. 56, Iss. 11, pp. 429-435
Open Access
Okuda Kosuke, Azusa Takahashi, Yoichi Furusawa, et al.
Nihon Toseki Igakkai Zasshi (2023) Vol. 56, Iss. 11, pp. 429-435
Open Access
